Second-line strategies after anti-TNF failure in chronically active, moderate-to-severe ulcerative colitis: a retrospective, multicentre cohort study

After first-line anti-TNF failure, switching to a non-anti-TNF agent is worth considering in moderate-to-severe UC.

Authors

Institutions

Publication Details

Journal
Expert Opinion on Biological Therapy
Published
2025-05-10
DOI
https://doi.org/10.1080/14712598.2025.2500962
Citations
1
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
1.82

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Second-line strategies after anti-TNF failure in chronically active, moderate-to-severe ulcerative colitis: a retrospective, multicentre cohort study

Zoltán Szepes, Bernadett Farkas, A Kagramanova, Jakob Benedict Seidelin et al.
1 citations
Expert Opinion on Biological Therapy
Inflammatory Bowel Disease
1.82
article

Second-line strategies after anti-TNF failure in chronically active, moderate-to-severe ulcerative colitis: a retrospective, multicentre cohort study

Zoltán Szepes, Bernadett Farkas, A Kagramanova, Jakob Benedict Seidelin, Mohamed Attauabi, Luisa Bertin, Milan Lukáš, Simone Saibeni, Fabiana Castiglione, Pál Miheller, Péter Bacsúr, E. Yu. Chashkova, Panu Wetwittayakhlang, Željko Krznarić, Mariann Borsos, F Vilmos, Edoardo Vincenzo Savarino, Davide Giuseppe Ribaldone, Nitsan Maharshak, Jimmy K. Limdi, Giorgos D. Michalopoulos, Patrícia Sarlós, Karishma Sethi-Arora, Livio Bonacci, Tamás F. Molnár, Galia Berman, Klaudia Farkas, Ariella Bar-Gil Shitrit, T Resál, P. Lakatos
article en
1 citations

Abstract

After first-line anti-TNF failure, switching to a non-anti-TNF agent is worth considering in moderate-to-severe UC.

Expert Opinion on Biological TherapyVol. 25(6)
Semmelweis University (HU), Prince of Songkla University (TH), University of Padua (IT), University Hospital Centre Zagreb (HR), Tel Aviv University (IL), University of Szeged (HU), Tel Aviv Sourasky Medical Center (IL), McGill University Health Centre (CA), Gentofte Hospital (DK), Northern Health and Social Care Trust (GB), Moscow Clinical Scientific Center (RU), General Hospital of Athens G. Genimatas (GR), Iscare I.V.F (CZ), Irkutsk Regional Clinical Hospital (RU), Scientific Research Institute of Healthcare Organization and Medical Management (RU), Zagreb School of Business (HR), Irkutsk Scientific Center of Surgery and Traumatology (RU), Azienda Ospedale - Università Padova (IT), University of Turin (IT), University of Naples Federico II (IT), University of Pecs (HU)
European Crohn's and Colitis Organisation, United European Gastroenterology, Szegedi Tudományegyetem, Innovation Fund, Nemzeti Kutatási, Fejlesztési és Innovaciós Alap, National Research, Development and Innovation Office
Good health and well-being
Openalex Percentile: Top 16%
Inflammatory Bowel Disease
1.82
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.